首页> 外文期刊>Research journal of pharmacy and technology >Formulation Development and Evaluation of Direct compressed Cefpodoxime proxetil Effervescent Tablets
【24h】

Formulation Development and Evaluation of Direct compressed Cefpodoxime proxetil Effervescent Tablets

机译:直接压缩头皮肟的配方开发和评估

获取原文
获取原文并翻译 | 示例
           

摘要

Cefpodoxime proxetil is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. It belongs to BCS class IV drugs and has a limited aqueous solubility of 0.4 mg/ml. Hence the present aim of the study is to enhance the solubility of Cefpodoxime proxetil through complexation with HP-P-cyclodextrin. Binary mixture of sodium bicarbonate and citric acid to be used as effervescent materials. The disintegration to be further enhanced using superdisintegrants such as croscarmellose sodium, sodium starchglycolate and polacrilin K. Seven such formulations were prepared with varying composition and proportion of superdisintegrants. All formulations indicated a fair weight variation with in the pharmacopoeial limit. The result varies from ±1.23% to ±3.58% against ±5%. Thickness range was determined between 4mm -4.2mm. Hardness test result revealed a good strength of more than 4.5 kg/cm2 in every tablet. The percent friability was found within the specification. All formulation took fair time for completion of effervescence except F1 that don’t contain any superdisintegrant. Drug content of all formulations were found to be excellent with more than 98%. Formulation F7 showed excellent effervescent time as compare to other formulation. It showed a consistent drug release with more than 80 % drug released in just 30 minutes. In the FTIR spectra, presence of all significant peaks of drug and absence of any new peak in the formulations revealed that there was no interaction of drug with the excipients. Hence the present study could be an excellent approach to the delivery of the poorly soluble Cefpodoxime proxetil as effervescent tablet.
机译:头孢普肟替补是口服施用的扩展光谱,半合成的头孢菌素类的半合成抗生素。它属于BCS A类药物,其具有0.4mg / ml的有限的水溶性。因此,该研究的目的是通过与HP-P-Cyclodextrin的络合来增强头孢哌酮替氏素的溶解度。碳酸氢钠和柠檬酸的二元混合物用作泡腾材料。使用超级分解剂如Croscarmellose钠,卤代糖酸钠和酚林蛋白K.制备七种这样的制剂,以改变组合物和超二聚体比例的制剂,以进一步增强崩解。所有制剂都表明了在药典中的相当体重变化。结果从±1.23%变化到±3.58%,±5%。厚度范围在4mm -4.2mm之间确定。硬度测试结果显示每个片剂中超过4.5kg / cm2的良好强度。在规范内发现了折损百分比。所有制定都采取了公平的时间来完成渗透性,除了不包含任何超级融合的F1。发现所有制剂的药物含量为优异,超过98%。配方F7显示与其他配方相比的优异的冒烟时间。它显示出一致的药物释放,仅在30分钟内释放超过80%的药物。在FTIR光谱中,在制剂中存在所有显着的药物峰和没有任何新峰的情况表明,药物与赋形剂没有相互作用。因此,本研究可能是将可溶性头孢会替补作为泡腾片剂的良好溶解性的头孢草细胞的优异方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号